The Texas Alzheimer’s Research and Care Consortium (TARCC) is a collaboration between ten of the state’s leading medical research institutions, working to improve early diagnosis, treatment, and prevention of Alzheimer’s disease.
Alzheimer's Facts
1 in 9 people age 65+ has Alzheimer's disease.
About 490,000 Texans are projected to have Alzheimer's by 2025.
1 in 3 seniors dies with Alzheimer's disease or another dementia. Every 66 seconds, someone in the United States develops Alzheimer’s.
Get Involved
– Legislative Corner
TARCC 2022 Scientific Symposium
Advances in Alzheimer’s Disease Science, Research, and Care
Save the date!
January 27, 2022
TARCC Research Updates
TARCC investigators have been involved in a number of new, important research studies. Recently published research is wide ranging, spanning the gamut from clinical trials to new cognitive diagnostics; blood-based biomarkers in Mexican-Americans; identification of additional risk genes; and validation of biomarker algorithms in AD patients and AD animal models.
View all TARCC researcher publications here.
View all TARCC Investigator Grant Awards here.
Read TARCC's Latest Facebook Posts:
Texas Alzheimer's Research and Care Consortium
Developed with the TARCC cohort, the Southwestern Assessment of Processing Speed (SWAPS) is a brief, free, and easily administered tool to be used in clinical and research settings for the detection of cognitive impairment and efficient assessment of processing speed.
www.tandfonline.com/doi/full/10.1080/13854046.2021.1970229
(2021). Southwestern Assessment of Processing Speed (SWAPS): A new brief test with demographically-corrected norms in an ethnically and educationally diverse population. The Clinical Neuropsychologist. Ahead of Print.
Texas Alzheimer's Research and Care Consortium
Please join us at the
TARCC Scientific Symposium: Advances in Alzheimer's Disease Science, Research, and Care
January 27, 2022
UT Austin Etter-Harbin Alumni Center// 2110 San Jacinto Blvd// Austin, TX
In-person with virtual options
conta.cc/39KuK2l
Texas Alzheimer's Research and Care Consortium
TARCC’s investment in our long-term cohort activities continues to contribute to important national research in rare genetic variants of neurodegenerative diseases.
journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1009772
Author summary Late-onset Alzheimer’s disease (LOAD) is the most common type of dementia and a leading cause of death in the world. Clinical and genetic studies have suggested the potential contribution of the cellular transportation pathway to AD with an emphasis on common variants. In this study...